Osobní účet
Osobní účet
Spruce Biosciences
Biopharmaceutical company that focuses on developing therapies for rare diseases that targets endocrine system
Uzávěrka
10/19/2020
Ziskovost
8.33%
O společnosti
Total Funding
$108M
Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company is driven by its mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.
Number of employees
1 - 10
Headquarters
San Francisco, California, United States